Literature DB >> 30419005

Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.

Gorka Ruiz de Garibay, Carmen Herranz, Alicia Llorente, Jacopo Boni, Jordi Serra-Musach, Francesca Mateo, Helena Aguilar, Laia Gómez-Baldó, Anna Petit, August Vidal, Fina Climent, Javier Hernández-Losa, Álex Cordero, Eva González-Suárez, José Vicente Sánchez-Mut, Manel Esteller, Roger Llatjós, Mar Varela, José Ignacio López, Nadia García, Ana I Extremera, Anna Gumà, Raúl Ortega, María Jesús Plà, Adela Fernández, Sònia Pernas, Catalina Falo, Idoia Morilla, Miriam Campos, Miguel Gil, Antonio Román, María Molina-Molina, Piedad Ussetti, Rosalía Laporta, Claudia Valenzuela, Julio Ancochea, Antoni Xaubet, Álvaro Casanova, Miguel Angel Pujana.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0132546.].

Entities:  

Year:  2018        PMID: 30419005      PMCID: PMC6231678          DOI: 10.1371/journal.pone.0207586

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


The following information is missing from the Funding section: This study was supported by the Spanish Ministry of Science and Innovation, European Regional Development Fund (FEDER).
  1 in total

1.  Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.

Authors:  Gorka Ruiz de Garibay; Carmen Herranz; Alicia Llorente; Jacopo Boni; Jordi Serra-Musach; Francesca Mateo; Helena Aguilar; Laia Gómez-Baldó; Anna Petit; August Vidal; Fina Climent; Javier Hernández-Losa; Álex Cordero; Eva González-Suárez; José Vicente Sánchez-Mut; Manel Esteller; Roger Llatjós; Mar Varela; José Ignacio López; Nadia García; Ana I Extremera; Anna Gumà; Raúl Ortega; María Jesús Plà; Adela Fernández; Sònia Pernas; Catalina Falo; Idoia Morilla; Miriam Campos; Miguel Gil; Antonio Román; María Molina-Molina; Piedad Ussetti; Rosalía Laporta; Claudia Valenzuela; Julio Ancochea; Antoni Xaubet; Álvaro Casanova; Miguel Angel Pujana
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

  1 in total
  1 in total

Review 1.  SOX9: The master regulator of cell fate in breast cancer.

Authors:  Samir Jana; B Madhu Krishna; Jyotsana Singhal; David Horne; Sanjay Awasthi; Ravi Salgia; Sharad S Singhal
Journal:  Biochem Pharmacol       Date:  2020-01-03       Impact factor: 6.100

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.